perfluorooctane sulfonic acid has been researched along with Cirrhosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Li, S; Luo, D; Xu, S; Yin, H; Zhang, J | 1 |
Deng, P; Hennig, B; Morris, AJ; Sexton, T; Wahlang, B; Wang, C | 1 |
Chang, CC; Chou, HC; Jin, L; Juan, SH; Lin, CY; Wen, LL | 1 |
3 other study(ies) available for perfluorooctane sulfonic acid and Cirrhosis
Article | Year |
---|---|
Cannabidiol alleviates perfluorooctane sulfonate-induced macrophage extracellular trap mediate inflammation and fibrosis in mice liver.
Topics: Animals; Cannabidiol; Chemical and Drug Induced Liver Injury; Extracellular Traps; Fibrosis; Inflammation; Macrophages; Mice; NF-kappa B | 2023 |
Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.
Topics: Alkanesulfonic Acids; Animals; Biomarkers; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Environmental Pollutants; Fibrosis; Fluorocarbons; Liver; Male; Mice; Mice, Inbred C57BL; Polychlorinated Biphenyls; Risk; Thrombosis | 2020 |
From the Cover: l-Carnitine via PPARĪ³- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
Topics: Acetylation; Alkanesulfonic Acids; Animals; Carnitine; Cell Line; Cell Movement; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Fluorocarbons; Kidney Diseases; Kidney Tubules; Male; Mice, Inbred BALB C; PPAR gamma; Protective Agents; Rats; Signal Transduction; Sirtuin 1; Time Factors; Transfection | 2017 |